Ocugen OCGN
NASDAQ OCGN
$0.79 -0.03 (-3.66%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ocugen (OCGN) Amortization of Deferred Charges (2014 - 2026)

Updated

Analysis

Ocugen (OCGN) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Ocugen 254.11 Mn 70.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Mn
Mar 31, 2026 400,000.00
Jun 30, 2025 -314,000.00
Mar 31, 2025 314,000.00
Dec 31, 2014 77,000.00
Sep 30, 2014 79,000.00
Jun 30, 2014 -80,000.00
Mar 31, 2014 -38,000.00
API Access

Ocugen Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=OCGN&period=max&api_key=YOUR_API_KEY